BioCentury
ARTICLE | Finance

Jan. 5 Quick Takes: Eventide leads mega-round by Korro

Plus Saliogen raises $115M series B and updates from DNA Script, Chance, RemeGen, AffaMed, Ray, Edgewise

January 6, 2022 1:41 AM UTC

Korro Bio Inc. raised a $116 million series B round to advance its RNA editing platform, enable clinical development of its lead program for alpha-1 antitrypsin deficiency, and expand its pipeline for ...



Access this Article